- Home
- BDTX vs FCO Comparison
BDTX vs FCO Comparison
Compare BDTX & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- FCO
- Stock Information
- Founded
- BDTX 2014
- FCO 1991
- Country
- BDTX United States
- FCO United Kingdom
- Employees
- BDTX N/A
- FCO N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- FCO Investment Managers
- Sector
- BDTX Health Care
- FCO Finance
- Exchange
- BDTX Nasdaq
- FCO Nasdaq
- Market Cap
- BDTX 96.9M
- FCO 80.3M
- IPO Year
- BDTX 2020
- FCO N/A
- Fundamental
- Price
- BDTX $1.61
- FCO $6.03
- Analyst Decision
- BDTX Strong Buy
- FCO
- Analyst Count
- BDTX 5
- FCO 0
- Target Price
- BDTX $15.60
- FCO N/A
- AVG Volume (30 Days)
- BDTX 8.2M
- FCO 100.1K
- Earning Date
- BDTX 03-06-2025
- FCO 01-01-0001
- Dividend Yield
- BDTX N/A
- FCO 14.96%
- EPS Growth
- BDTX N/A
- FCO N/A
- EPS
- BDTX N/A
- FCO 0.43
- Revenue
- BDTX N/A
- FCO N/A
- Revenue This Year
- BDTX N/A
- FCO N/A
- Revenue Next Year
- BDTX N/A
- FCO N/A
- P/E Ratio
- BDTX N/A
- FCO $12.30
- Revenue Growth
- BDTX N/A
- FCO N/A
- 52 Week Low
- BDTX $1.55
- FCO $4.73
- 52 Week High
- BDTX $7.66
- FCO $6.63
- Technical
- Relative Strength Index (RSI)
- BDTX 38.60
- FCO 47.61
- Support Level
- BDTX $1.55
- FCO $6.01
- Resistance Level
- BDTX $1.84
- FCO $6.25
- Average True Range (ATR)
- BDTX 0.23
- FCO 0.10
- MACD
- BDTX 0.01
- FCO -0.01
- Stochastic Oscillator
- BDTX 5.26
- FCO 40.54
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.